Stability of Formulation Solutions on Various AAV Serotypes
Time: 2:10 pm
day: Track C - Day 2 PM
Details:
- Formulation challenges in the context of Gtx drug development
- Stability Variations in different AAV serotypes
- Formulation feedback from regulators
